MAD1L1 Antikörper (AA 186-235)
-
- Target Alle MAD1L1 Antikörper anzeigen
- MAD1L1 (MAD1 Mitotic Arrest Deficient-Like 1 (MAD1L1))
-
Bindungsspezifität
- AA 186-235
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser MAD1L1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Spezifität
- Human MAD1L1 / MAD1
- Aufreinigung
- Immunoaffinity purified
- Immunogen
-
Synthetic peptide located between aa186-235 of human MAD1L1 (Q9Y6D9, NP_003541). Percent identity by BLAST analysis: Human (100%).
Type of Immunogen: Synthetic peptide - Top Product
- Discover our top product MAD1L1 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Kommentare
-
Target Species of Antibody: Human
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Distilled water
- Konzentration
- Lot specific
- Buffer
- Lyophilized from PBS
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
- Target
- MAD1L1 (MAD1 Mitotic Arrest Deficient-Like 1 (MAD1L1))
- Andere Bezeichnung
- MAD1L1 / MAD1 (MAD1L1 Produkte)
- Synonyme
- MAD1 antikoerper, PIG9 antikoerper, TP53I9 antikoerper, TXBP181 antikoerper, AI173502 antikoerper, AW550425 antikoerper, Mad1 antikoerper, zgc:56571 antikoerper, MAD1-like protein 1 antikoerper, mitotic arrest deficient 1 like 1 antikoerper, MAD1 mitotic arrest deficient like 1 antikoerper, MAD1 mitotic arrest deficient 1-like 1 antikoerper, deafness, autosomal recessive 19 antikoerper, MAD1L1 antikoerper, Mad1l1 antikoerper, mad1l1 antikoerper, DFNB19 antikoerper
- Hintergrund
-
Name/Gene ID: MAD1L1
Synonyms: MAD1L1, HMAD1, MAD1, MAD1-like protein 1, Tax-binding protein 181, TP53I9, PIG9, HSMAD1, Tax1-binding protein txbp181, TXBP181 - Gen-ID
- 8379
- NCBI Accession
- NP_003541
- UniProt
- Q9Y6D9
- Pathways
- M Phase
-